No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Pavmed's Strategic Growth and Financial Challenges
PAVmed Shares Are Trading Higher on Possible Continued Strength After the Company Reported a Q4 Adjusted EPS Beat on Tuesday.
PAVmed Reports Strong Q4 Results and Strategic Progress
Q4 2024 PAVmed Inc Earnings Call
PAVmed Inc. (PAVM) Q4 2024 Earnings Call Transcript Summary
PAVmed Outlines Strategic Milestones for 2025, Including Veris Implantable Device Submission